FDA recall record

Advanced Pharma Oxytocin 30 Units added to NS 500 mL recall — FDA D-0499-2019

Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Class IIIclassification
D-0499-2019official record ID
Feb 27, 2019report date

Recall record at a glance

Official recordD-0499-2019
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmAdvanced Pharma Inc.
Report dateFeb 27, 2019
Recall initiation dateFeb 6, 2019
Quantity1460 bottles
LocationHouston, TX, United States

Official product description

Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.

Why the product was recalled

Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Distribution information

Nationwide in the USA.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.